MRSA Research Center

The University of Chicago Medical Center

  • Welcome
  • Patients
  • Clinicians
  • Researchers
  • Education & Training
  • Alumni

For Clinical Researchers – Clinical References

2012

David MZ, Rudolph KM, Hennessey TB, Zychowski DL, Asthi K, Boyle-Vavra S, Daum RS. MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000-2006. Emerging Infectious Diseases 2012;18:105-8.

Gould IM, David MZ, Esposito S, Garau J, Lina G, Mazzei T, Peters G. New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int J Antimicrob Agents 2012 Feb;39(2):96-104.

Daum RS, Spellberg B. Progress Toward a Staphylococcus aureus Vaccine. Clin Infect Dis 2011 Dec 20. [Epub ahead of print]

2011 

Myers PJ, Marcinak J, David MZ, Zychowski DL, Boyle-Vavra S, Weber S, Daum RS. Universal admission screening for methicillin-resistant Staphylococcus aureus (MRSA) in a level IIID neonatal intensive care unit (NICU): the first 9 months. Infection Control and Hospital Epidemiology 2011;32:398-400.

David MZ, Boyle-Vavra S, Zychowski DL, Daum RS. Methicillin-Susceptible Staphylococcus aureus as a Predominantly Healthcare-Associated Pathogen: A Possible Reversal of Roles? PLoS One. 2011 Apr 13;6(4):e18217

Dukic VM, David MZ, Lauderdale DS. Internet Queries and MRSA Surveillance. Emerging Infectious Diseases. 2011;17(6):1068-1070.

Keane E. National group releases first guidelines for the treatment of MRSA. Medill Reports: Chicago. Jan. 12, 2011.

Cadilla A, David MZ, Daum RS, Boyle-Vavra S. Association of High-Level Mupirocin Resistance and Multidrug-Resistant Methicillin-Resistant Staphylococcus aureus at an Academic Center in the Midwestern United States. J Clin Microbiol. 2011 Jan;49(1):95-100.

2010

David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010 Jul;23(3):616-87.

Hoehn KS, Capouya JD, Daum RS, Glikman D, Gossett JG, Hafzalah M, Johnson D, Marcinak J. Lemierre-like syndrome caused by community-associated methicillin-resistant Staphylococcus aureus complicated by hemorrhagic pericarditis. Pediatric Critica Care Medicine 2010;11(3):e32-35.

Macario E, Daum RS, Eells SJ, Miller LG. Using cognitive interviews to refine a household contacts survey on the epidemiology of community-associated methicillin resistant Staphylococcus aureus. Journal of Infection Prevention 2010;11(2):44-48.

2009

Daum RS. Epidemic Community Associated Methicillin Resistant Staphylococcus aureus Infections. Increasingly, Everyone's Problem. J AAPOS. 2009, 13:225-6.

Klein E, Smith DL, Laxminarayan R. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States 1999-2006. Emerging Infectious Diseases 2009;15(12). Available from http://www.cdc.gov/EID/content/15/12/1925.htm

Crawford SE, David MZ, Glikman D, King KJ, Boyle-Vavra S, Daum RS. Clinical importance of purulence in methicillin-resistant Staphylococcus aureus skin and soft tissue infections. J Am Board Fam Med 2009;22:647-654.

Burman W, Daum R. Grinding to a halt: The effects of the increasing regulatory burden on research and quality improvement efforts. Clinical Infectious Diseases (CID) 2009;49:328-335.

2008

David MZ, Rudolph KM, Hennessey TB, Boyle-Vavra S, Daum RS. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in rural southwest Alaska. Emerging Infectious Diseases. 2008;14(11):1693-9.

Daum RS. Removing the Golden Coat of Staphylococcus aureus. N Eng J Med Clinical Implications of Basic Research), 359:85-87, 2008.

Crawford SE, Daum RS. Bacterial pneumonia, lung abscess, and empyema. In Taussig LM, Landau LI, Le Souef PN, Morgan WJ, Martinez FD, Sly PD. Pediatric Respiratory Medicine, Mosby Elsevier, Philadelphia, Pa, 2008, pp 501-554.

Daum RS.  Staphylococcus aureus vaccines.  In Plotkin S, Orenstein W, Offit P.  Vaccines, 5th edition, 2008, pp 1307-1315.

David MZ, Daum RS.  Endemic methicillin-resistant Staphylococcus aureus skin and soft tissue infections in a large urban jail: risk factors and recurrence rates.  J Clin Micro 2008;46:3222-3227.

David MZ, Glikman D, Crawford SE, Peng J, King KJ, Hostetler MA, Boyle-Vavra S, Daum RS.  What is community-associated methicillin-resistant Staphylococcus aureus?  J Infect Dis 2008;197:1235-1243.

Glikman D, Siegel JD, David MZ, Okuro NM, Boyle-Vavra S, Dowell ML, Daum RS.  Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) isolates from children with cystic fibrosis in the era of epidemic community-associated MRSA. Chest 2008;133:1381-1387.

Lowell G, Daum RS. Staphylococcus aureus infections. In Long SS, Pickering LK, Prober CG. Principles and Practice of Pediatric Infectious Diseases, 3rd edition, 2008, pp 679-693.

2007

Daum RS. The treatment of community-associated methicillin-resistant Staphylococcus aureus infections. N Eng J Med 2007;357:380-390.

Maree C, Daum RS, Boyle-Vavra, Miller LG.  A rapid increase in "community-associated" methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated Infections.  Emerg Inf Dis 2007;13:236-242.

2006

Crawford S, Boyle-Vavra S, Daum RS.  Community associated methicillin-resistant Staphylococcus aureus.  In Scheld M, Hooper D, Hughes JM, eds. Emerging Infections 7, 2006, pp 153-170.

Crawford SE, Daum RS. Therapy of staphylococcal infections.  In Burg, Ingelfinger J, Polin, Gershon A.  Current Pediatric Therapy, 18th edition, in press, 2006.

David MZ, Crawford SE, Boyle-Vavra S, Kim DC, Daum RS.  Comparing antibiotic resistance among community-associated methicillin-resistant Staphylococcus aureus isolates from adults and children.  Emerg Inf Dis 2006;12:631-637.

Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA and Participants in the Centers for Disease Control and Prevention-Convened Experts’ Meeting on Management of MRSA in the Community (RS Daum, Participating author), 2006. Available at http://www/cdc/gov/ncidod/dhqp/ar-mrsa-ca.html.

2005

Adem PV, Montgomery CP, Husain AN, Koogler TK, Arangelovich V, Humilier M, Boyle-Vavra S, Daum RS.  Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children.  N Eng J Med 2005;353:1245-1251.

Crawford SE, Daum RS.  Epidemic community-associated methicillin-

resistant Staphylococcus aureus: modern times for an ancient pathogen.  Pediatr Inf Dis 2005;24:459-460.

Mongkolrattanothai K, Daum RS.  Impact of community-associated methicillin-resistant Staphylococcus aureus on management of skin and soft tissue infections in children.  Curr Infect Dis Reports 2005;7:381-389.

2004

Gregerson A, Daum RS. Staphylococcus aureus Vaccine.  In Plotkin SA, Orenstein WA (eds), Vaccines. 4th edition.  WB Saunders Co, Philadelphia, 2004. pp 1347–1355.

2003

Seal JB, Moreira B, Bethel CD, Daum RS.  Antimicrobial resistance in Staphylococcus aureus at the University of Chicago Hospitals: 15-year longitudinal assessment in a large university-based hospital.  Infect Control Hosp Epidem 2003;42:403-408.

2001

Daum RS, Seal J.  Evolving antimicrobial therapy for Staphylococcus aureus infections: our backs to the wall.  Crit Care Med 2001;29:N92-N96 (suppl).

Hussain FM, Boyle-Vavra S, Daum RS.  Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic.  Pediatr Infect Dis J 2001;20:763-767.

2000

Hussain FM, Boyle-Vavra S, Bethel CD, Daum RS.  Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility.  Pediatr Infect Dis J 2000;19:1163-1166.

Lin PL, Oram RJ, Lauderdale D. Dean R, Daum RS.  Knowledge of CDC guidelines for the use of vancomycin in a large tertiary care children’s hospital.  J Pediatr 2000;137:694-700.

1999

Jain A, Daum RS.  Staphylococcal infections in children. Part 1.  Pediatr in Rev 1999;20:183-191.

Jain A, Ben-Ami T, Daum RS.  Staphylococcal infections in children. Part 2.  Pediatr in Rev 1999;20:219-227.

Jain A, Daum RS.  Staphylococcal infections in children. Part 3.  Pediatr in Rev 1999;20:261-265.

Suggs AH, Maranan MC, Boyle-Vavra S, Daum RS.  Methicillin resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors.  Pediatr Infect Dis J 1999;18:410-414.

1998

Daum RS.  Community-acquired methicillin-resistant Staphylococcus aureus infections in children.  Pediatr Infect Dis J 1998;17:745-746.

Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS.  Community acquired methicillin resistant Staphylococcus aureus infections in children without traditional risk factors for infection.  JAMA 1998;279:593-598.

1997

Maranan M, Moreira B, Boyle-Vavra S, Daum RS.  Antimicrobial resistance in the staphylococci.  Molecular mechanisms, epidemiology and clinical relevance.  Inf Dis Clin NA 1997;11:813-849.

1995

Moreira B, Daum RS.  Antibiotic resistance in the staphylococci.  Pediatr Clin NA 1995;42:619-648.